A detailed history of Fmr LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Fmr LLC holds 1,827,720 shares of WVE stock, worth $12.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,827,720
Previous 1,540,190 18.67%
Holding current value
$12.5 Million
Previous $12.6 Million 79.02%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$8.0 - $16.44 $2.3 Million - $4.73 Million
287,530 Added 18.67%
1,827,720 $22.6 Million
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $5.01 Million - $8.82 Million
979,110 Added 174.5%
1,540,190 $12.6 Million
Q2 2024

Aug 13, 2024

SELL
$4.38 - $6.48 $2.66 Million - $3.94 Million
-607,693 Reduced 51.99%
561,080 $2.8 Million
Q1 2024

May 13, 2024

SELL
$3.54 - $6.84 $118,384 - $228,743
-33,442 Reduced 2.78%
1,168,773 $7.21 Million
Q4 2023

Feb 13, 2024

BUY
$4.16 - $6.87 $2.25 Million - $3.72 Million
541,790 Added 82.04%
1,202,215 $6.07 Million
Q3 2023

Nov 13, 2023

SELL
$3.56 - $5.75 $405,352 - $654,712
-113,863 Reduced 14.71%
660,425 $3.8 Million
Q2 2023

Aug 11, 2023

SELL
$3.51 - $4.69 $916,980 - $1.23 Million
-261,248 Reduced 25.23%
774,288 $2.82 Million
Q1 2023

May 11, 2023

SELL
$3.58 - $6.3 $2.6 Million - $4.57 Million
-725,900 Reduced 41.21%
1,035,536 $4.48 Million
Q4 2022

Feb 13, 2023

SELL
$3.18 - $7.0 $1.1 Million - $2.42 Million
-346,300 Reduced 16.43%
1,761,436 $12.3 Million
Q3 2022

Nov 10, 2022

BUY
$2.37 - $4.28 $2.06 Million - $3.72 Million
869,710 Added 70.25%
2,107,736 $7.61 Million
Q2 2022

Aug 12, 2022

BUY
$1.23 - $3.25 $1.44 Million - $3.81 Million
1,171,432 Added 1759.07%
1,238,026 $4.02 Million
Q1 2022

May 13, 2022

BUY
$2.0 - $3.28 $133,188 - $218,428
66,594 New
66,594 $133,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $593M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.